Chris Miskel

President and CEO - Versiti

Chris became President and CEO of Versiti on Feb. 1, 2017, after a 20+ year career exclusively in healthcare. He is first and foremost a patient and donor advocate, while also passionate about the employee experience of 2,000+ Versiti colleagues across multiple states. Chris and his leadership team have built a One Versiti culture, stoked the flame of innovation both organically and inorganically, invested in infrastructure, established Ohio as a 5th Versiti state, and led the organization to surpass $380M in annual revenue.

Prior to joining Versiti, Chris served as Group Vice President and Global Immunology Franchise Head at Shire, helping to bring medicines to patients around the world and shaping the strategy for a $2.5 billion biopharmaceutical franchise. In his previous role at Baxalta, he was Vice President of Plasma Strategy and New Product Development. Chris also worked for Baxter International as Vice President of U.S. BioScience National Accounts and spent 17 years with Eli Lilly and Company, most recently as General Manager of their Australia and New Zealand operation.

Chris earned a master’s in business administration from Harvard Business School in 2000 and a bachelor’s degree, cum laude in Accounting, from Butler University in 1996. He also was a three-year starter on Butler’s basketball team, and named an Academic All-American in 1995.

In June 2021, Chris joined the Butler University Board of Trustees. He was also appointed to the Board of Directors of Arthur J. Gallagher & Co. (NYSE: AJG) in March 2020; elected to the Medical College of Wisconsin board in 2018; and is a member of the Executive Committee of the Board of Blood Centers of America.

Chris and his wife Nicole live in Whitefish Bay, Wisconsin, and stay busy with their three children Sage, Mace, and Crew.